top of page

BLUEBERRIES MEDICAL CORP ANNUAL GENERAL MEETING 2023

SEDAR RETURN CARD

BBM FS Q2 2023

GENERAL INFORMATION

Blueberries Medical Corp. is a Latin American company with all the licenses granted by the Ministries of Justice and Health of Colombia, necessary to produce naturally grown premium Cannabis with low and high contents of THC and commercialize, manufacture and export derived products, with its primary operations ideally located in the Bogotá Savannah of central Colombia.

​

Blueberries Medical Corp is listed in the following markets: (CSE: BBM) (OTC: BBRRF) (FRA: 1OA)

INVESTOR PRESENTATION

2019

Q4 2019

Management's Discussion And Analysis Of Financial Condition And Results Of Operations For The Year Ended December 31,2019

Audited Consolidated Financial Statements For The Year Ended December 31, 2019 And For The Period From September 5, 2018 (Date Of Incorporation) To December 31, 2018

Q3 2019

Management's Discussion And Analysis Of Financial Condition And Results Of Operations For The Three And Six Months Ended September 30, 2019

Condensed Interim Consolidated Financial Statements For The Three And Six Months Ended September 30,2019

Q2 2019

Management's Discussion And Analysis Of Financial Condition And Results Of Operations For The Three And Six Months Ended June 30, 2019

Condensed Interim Consolidated Financial Statements For The Three And Six Months Ended June 30, 2019

Q1 2019

Financial Statements For The Three Months Ended March 31, 2019

Management's Discussion And Analysis For The Three Months Ended March 31, 2019

INVESTOR RELATIONS

Guillermo Rodriguez

CFO 

     grodriguez@blueberriesmed.com

     +54 91160152227

STOCK INFORMATION
bottom of page